Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2005
07/20/2005CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
07/20/2005CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
07/20/2005CN1211372C Method for prepn N-alkyl-N'-methyl alkyl urea selenite basically free from formic acid
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/20/2005CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/19/2005US6919339 ABCA-1 elevating compounds
07/14/2005WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005WO2005063722A1 Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates
07/14/2005WO2005063721A1 Herbicidal pyrimidines
07/14/2005WO2005063720A1 Amide derivative and medicine
07/14/2005WO2005063719A1 Substituted dihydropyrimidinone preparation using polyaniline salt catalyst
07/14/2005WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
07/14/2005US20050155087 Method of screening compounds
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154203 Method for producing 2-anilino-4,6-dimethylpyrimidine
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050153995 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof
07/14/2005US20050153988 Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
07/14/2005US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof
07/14/2005DE4111991B4 1,4-Disubtituierte 2,6-Difluorbenzolverbindungen und deren Verwendungen 1,4-Disubtituierte 2,6-Difluorbenzolverbindungen and their uses
07/14/2005CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/13/2005EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore
07/13/2005EP1553090A1 Process for producing pyrimidine compound
07/13/2005EP1553085A1 Cyclic amine derivatives and their use as drugs
07/13/2005EP1551962A2 Mitotic kinesin binding site
07/13/2005EP1551834A1 Substituted quinazolinone compounds
07/13/2005EP1551829A2 Novel compounds with antibacterial activity
07/13/2005EP1551812A2 Mitotic kinesin inhibitors
07/13/2005EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
07/13/2005EP1551795A1 Inhibitors of histone deacetylase
07/13/2005EP1551398A1 Pyrazolopyridines and methods of making and using the same
07/13/2005EP1171443B1 Bicyclic heteroaromatic compounds useful as lh agonists
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/13/2005CN1639131A Pyrimidine compounds and their use as pesticides
07/13/2005CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
07/13/2005CN1639125A New inhibitors of histone deacetylase
07/13/2005CN1639112A Substituted amides active at the cannabinoid-1 receptor
07/13/2005CN1638805A Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636981A Uracil compounds and their use
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1210279C Thiazolo (4,5-D) pyrimidine compounds
07/13/2005CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use
07/13/2005CN1210266C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methysulfonyl)amino]pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid
07/13/2005CN1210028C Aqueous liquid preparation
07/12/2005US6916850 Pyruvate derivatives
07/12/2005US6916820 Neurotrophic substituted pyrimidines
07/12/2005US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use
07/12/2005CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/07/2005WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005WO2005061466A1 Novel phenylalanine derivative
07/07/2005WO2005061465A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors
07/07/2005WO2005061459A1 Biaryl sulfonamides and methods for using same
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005WO2005060970A1 Pyrimidines with tie2 (tek) activity
07/07/2005WO2005060969A1 Pyrimidines with tie2 (tek) activity
07/07/2005WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005WO2005060654A2 Mitotic kinesin inhibitors
07/07/2005WO2005060456A2 Method for treating adamts-5-associate disease
07/07/2005WO2005049593A3 N-acylsulfonamide apoptosis promoters
07/07/2005WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
07/07/2005WO2004058704A3 Quinazolinones as potassium channel modulators
07/07/2005WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/07/2005US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals
07/07/2005US20050148623 HIV protease inhibiting compounds
07/07/2005US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/07/2005US20050148611 Compounds capable of activating cholinergic receptors
07/07/2005US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives
07/07/2005US20050148603 Compositions useful as inhibitors of protein kinases
07/07/2005US20050148473 Substituted sulfonylaminomethylbenzoic acid ( derivatives) and their preparation
07/07/2005DE10358539A1 Carbonsäureamidderivate Carboxamide
07/07/2005DE10356099A1 Organisches Elektrolumineszenzelement An organic electroluminescent
07/07/2005CA2550843A1 Novel phenylalanine derivatives
07/07/2005CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005CA2549184A1 6-(aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
07/07/2005CA2548513A1 Biaryl sulfonamides and methods for using same
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/07/2005CA2547617A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
07/07/2005CA2547575A1 Method for treating adamts-5-associated disease
07/07/2005CA2547209A1 Mitotic kinesin inhibitors
07/07/2005CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/06/2005EP1549621A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
07/06/2005EP1549614A2 Vasculostatic agents and methods of use thereof
07/06/2005EP1549600A1 Ketones
07/06/2005EP1549316A1 INHIBITORS OF TFG&bgr;
07/06/2005EP1549283A1 Merocyanine derivatives for cosmetic use
07/06/2005EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties
07/06/2005CN1636000A 5-substituted arylpyrimidines
07/06/2005CN1634888A Process for preparing acetyl substituted nitrogen containing heterocyclic compound
07/06/2005CN1209336C Process for preparation of 2-halobenzoic acids
07/05/2005CA2220509C Fused polycyclic heterocycle derivatives
07/05/2005CA2160928C Compounds as pde iv and tnf inhibitors
06/2005
06/30/2005WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005WO2005058311A1 Heterocyclic aspartyl protease inhibitors
06/30/2005WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity